Intratumoral Injections of LL37 for Melanoma
Clinical trial NCT02225366 · COMPLETED
Trial details
- NCT number
- NCT02225366
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-08
- Primary completion
- 2020-11-24
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.